US7306914B2
(en)
*
|
1997-01-31 |
2007-12-11 |
Odyssey Thera Inc. |
Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
|
US6897017B1
(en)
*
|
1997-01-31 |
2005-05-24 |
Odyssey Thera Inc. |
Vivo library-versus-library selection of optimized protein-protein interactions
|
US7062219B2
(en)
*
|
1997-01-31 |
2006-06-13 |
Odyssey Thera Inc. |
Protein fragment complementation assays for high-throughput and high-content screening
|
CA2196496A1
(en)
*
|
1997-01-31 |
1998-07-31 |
Stephen William Watson Michnick |
Protein fragment complementation assay for the detection of protein-protein interactions
|
US20020064769A1
(en)
*
|
2000-10-05 |
2002-05-30 |
Watson Michnick Stephen William |
Dynamic visualization of expressed gene networks in living cells
|
US6342345B1
(en)
|
1997-04-02 |
2002-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by reporter subunit complementation
|
AU736836B2
(en)
|
1997-07-07 |
2001-08-02 |
Medical Research Council |
In vitro sorting method
|
US6333154B1
(en)
*
|
1997-12-04 |
2001-12-25 |
Institut Pasteur |
Bacterial multi-hybrid system and applications thereof
|
US20050221280A1
(en)
*
|
1998-02-02 |
2005-10-06 |
Odyssey Thera, Inc. |
Protein-protein interactions for pharmacological profiling
|
US7166424B2
(en)
*
|
1998-02-02 |
2007-01-23 |
Odyssey Thera Inc. |
Fragments of fluorescent proteins for protein fragment complementation assays
|
US6828099B2
(en)
*
|
1998-02-02 |
2004-12-07 |
Odyssey Thera Inc. |
Protein fragment complementation assay (PCA) for the detection of protein-protein, protein-small molecule and protein nucleic acid interactions based on the E. coli TEM-1 β-Lactamase
|
US7855167B2
(en)
*
|
1998-02-02 |
2010-12-21 |
Odyssey Thera, Inc. |
In vivo screening of protein-protein interactions with protein-fragment complementation assays
|
WO2000018885A1
(en)
*
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
WO2000007014A2
(en)
|
1998-07-28 |
2000-02-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Leptin-mediated gene-induction
|
EP1027608B1
(en)
*
|
1998-07-30 |
2010-01-20 |
Odyssey Thera, Inc. |
Protein fragment complementation assays
|
CA2345392A1
(en)
*
|
1998-09-24 |
2000-03-30 |
Duke University |
Method of measuring protein-protein interactions in living cells
|
US20040038317A1
(en)
*
|
1999-03-15 |
2004-02-26 |
Kalobios, Inc. |
Breakpoint fusion fragment complementation system
|
US8148110B2
(en)
|
1999-03-15 |
2012-04-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by β-lactamase reporter fragment complementation
|
AU780002B2
(en)
*
|
1999-05-24 |
2005-02-24 |
Boston Biomedical Research Institute Incorporated |
Method for generating split, non-transferable genes that are able to express an active protein product
|
US20040096938A1
(en)
*
|
1999-05-24 |
2004-05-20 |
Ming-Qun Xu |
Method for generating split, non-transferable genes that are able to express an active protein product
|
EP1183347A1
(en)
*
|
1999-05-25 |
2002-03-06 |
Panorama Research, Inc. |
Interaction-activated proteins
|
US6673554B1
(en)
*
|
1999-06-14 |
2004-01-06 |
Trellie Bioinformatics, Inc. |
Protein localization assays for toxicity and antidotes thereto
|
CA2377513A1
(en)
*
|
1999-06-25 |
2001-01-04 |
Universitat Zurich |
Hetero-associating coiled-coil peptides
|
AU6054900A
(en)
*
|
1999-06-26 |
2001-01-31 |
Odyssey Pharmaceuticals, Inc. |
An in vivo library-versus-library selection of optimized protein-protein interactions
|
WO2001001137A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Children's Medical Center Corporation |
Fusion protein and uses thereof
|
WO2001007598A1
(en)
*
|
1999-07-22 |
2001-02-01 |
Children's Medical Center Corporation |
EXPRESSION CLONING USING A TAGGED cDNA LIBRARY
|
EP1248840A2
(en)
*
|
2000-01-13 |
2002-10-16 |
Panorama Research, Inc. |
Circularly permutated, interaction-activated proteins
|
WO2001053479A2
(en)
*
|
2000-01-24 |
2001-07-26 |
Sangamo Biosciences, Inc. |
Molecular switches ii
|
WO2001060840A2
(en)
*
|
2000-02-14 |
2001-08-23 |
Board Of Regents, The University Of Texas System |
Complementation assay assessing protein solubility and folding
|
US6727070B2
(en)
|
2000-02-14 |
2004-04-27 |
The Board Of Regents, The University Of Texas System |
Protein/solubility folding assessed by structural complementation
|
CA2384561A1
(en)
|
2000-05-12 |
2001-11-22 |
Yale University |
Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
|
WO2001088168A2
(en)
*
|
2000-05-12 |
2001-11-22 |
Odyssey Pharmaceuticals, Inc. |
Mapping molecular interactions in plants with protein fragments complementation assays
|
EP1283878B1
(en)
*
|
2000-05-22 |
2005-07-27 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Receptor-based interaction trap
|
EP2149604A1
(en)
|
2000-09-08 |
2010-02-03 |
Universität Zürich |
Collections of repeat proteins comprising repeat modules
|
GB0022458D0
(en)
*
|
2000-09-13 |
2000-11-01 |
Medical Res Council |
Directed evolution method
|
US20030165873A1
(en)
*
|
2001-03-02 |
2003-09-04 |
Come Jon H. |
Three hybrid assay system
|
DE10110449A1
(de)
*
|
2001-03-05 |
2002-09-19 |
Lisa Wiesmueller |
Testsystem zur Bestimmung von Genotoxizitäten
|
US20020177217A1
(en)
*
|
2001-03-26 |
2002-11-28 |
Massachusetts Institute Of Technology |
Method for studying protein-protein interactions
|
WO2002090593A1
(en)
*
|
2001-05-09 |
2002-11-14 |
Discoverx, Inc. |
Screening for enzyme inhibitors
|
EP1499885B1
(en)
*
|
2001-08-01 |
2009-10-21 |
Cellomics, Inc. |
Novel fusion proteins and assays for molecular binding
|
GB0118995D0
(en)
*
|
2001-08-03 |
2001-09-26 |
Univ Wales Medicine |
Detection of mutations in nucleic acids
|
PT1434871T
(pt)
|
2001-09-20 |
2017-04-05 |
Immunex Corp |
Seleção de células que expressam polipéptidos heteroméricos
|
AU2007200686B2
(en)
*
|
2001-09-20 |
2011-07-14 |
Immunex Corporation |
Selection of cells expressing heteromeric polypeptides
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
EP1451214A2
(en)
|
2001-11-26 |
2004-09-01 |
Hybrigenics |
Protein-protein interactions in human immunodeficiency virus
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
*
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US6936427B2
(en)
*
|
2002-02-08 |
2005-08-30 |
Trellis Bioscience, Inc. |
Real time detection of intermolecular interaction
|
US7432063B2
(en)
*
|
2002-02-14 |
2008-10-07 |
Kalobios Pharmaceuticals, Inc. |
Methods for affinity maturation
|
US7335478B2
(en)
*
|
2002-04-18 |
2008-02-26 |
Kalobios Pharmaceuticals, Inc. |
Reactivation-based molecular interaction sensors
|
SE0200531D0
(sv)
*
|
2002-02-22 |
2002-02-22 |
Avaris Ab |
Novel biomolecular complexes, method for their production and use
|
DE60317330T2
(de)
*
|
2002-03-25 |
2008-08-21 |
Applera Corp., Bedford |
Systeme und verfahren zum nachweis der funktion nukleärer rezeptoren unter verwendung von reporterenzymmutanten komplementierungen
|
AU2003234327B2
(en)
*
|
2002-05-01 |
2008-05-29 |
Trellis Bioscience, Inc. |
Binary or polynary targeting and uses thereof
|
GB0214553D0
(en)
*
|
2002-06-25 |
2002-08-07 |
Univ Leeds |
Reporter module molecules having active ion channel activity
|
WO2004033485A2
(en)
*
|
2002-10-09 |
2004-04-22 |
The Trustees Of Boston University |
Nucleic acid supported protein complementation
|
US9740817B1
(en)
|
2002-10-18 |
2017-08-22 |
Dennis Sunga Fernandez |
Apparatus for biological sensing and alerting of pharmaco-genomic mutation
|
WO2005003375A2
(en)
|
2003-01-29 |
2005-01-13 |
454 Corporation |
Methods of amplifying and sequencing nucleic acids
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
WO2005001115A2
(en)
*
|
2003-05-30 |
2005-01-06 |
Odyssey Thera, Inc. |
Monitoring gene silencing and annotating gene function in living cells
|
EP1641809B2
(en)
|
2003-07-05 |
2018-10-03 |
The Johns Hopkins University |
Method and compositions for detection and enumeration of genetic variations
|
US8346482B2
(en)
|
2003-08-22 |
2013-01-01 |
Fernandez Dennis S |
Integrated biosensor and simulation system for diagnosis and therapy
|
WO2005038029A2
(en)
|
2003-10-10 |
2005-04-28 |
Promega Corporation |
Luciferase biosensor
|
GB0329353D0
(en)
*
|
2003-12-19 |
2004-01-21 |
Amersham Biosciences Uk Ltd |
Cytochrome C protein and assay
|
US20050186606A1
(en)
*
|
2004-02-11 |
2005-08-25 |
Schroeder Benjamin G. |
Methods and compositions for detecting nucleic acids
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
AU2005250333A1
(en)
*
|
2004-04-16 |
2005-12-15 |
Genentech, Inc. |
Omi PDZ modulators
|
US20060292554A1
(en)
*
|
2004-05-18 |
2006-12-28 |
Genentech, Inc. |
Major coat protein variants for C-terminal and bi-terminal display
|
EP2400030B1
(en)
|
2004-05-18 |
2016-01-20 |
The Board of Trustees of the Leland Stanford Junior University |
Detection of protein translocation by beta-galactosidase reporter fragment complementation
|
US20090221440A1
(en)
*
|
2004-07-12 |
2009-09-03 |
Board Of Regents, The University Of Texas System |
Methods and compositions related to identifying protein-protein interactions
|
CA2574881C
(en)
|
2004-08-04 |
2013-01-08 |
Amgen Inc. |
Antibodies to dkk-1
|
US20060040338A1
(en)
|
2004-08-18 |
2006-02-23 |
Odyssey Thera, Inc. |
Pharmacological profiling of drugs with cell-based assays
|
EP1799812A4
(en)
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS
|
US20060094059A1
(en)
*
|
2004-09-22 |
2006-05-04 |
Odyssey Thera, Inc. |
Methods for identifying new drug leads and new therapeutic uses for known drugs
|
EP1797427A4
(en)
*
|
2004-09-22 |
2009-04-08 |
Odyssey Thera Inc |
METHOD FOR IDENTIFYING NEW MEDICAMENT LEADS AND NEW THERAPEUTIC USES OF KNOWN MEDICAMENTS
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
US20060094682A1
(en)
|
2004-10-29 |
2006-05-04 |
Odyssey Thera, Inc. |
Kinase inhibitors for the treatment of diabetes and obesity
|
EP1812038A1
(en)
|
2004-11-18 |
2007-08-01 |
VIB vzw |
Fibronectin iii domain as leptin receptor antagonists
|
US20060160109A1
(en)
*
|
2004-11-22 |
2006-07-20 |
Odyssey Thera, Inc. |
Harnessing network biology to improve drug discovery
|
US20070212677A1
(en)
*
|
2004-11-22 |
2007-09-13 |
Odyssey Thera, Inc. |
Identifying off-target effects and hidden phenotypes of drugs in human cells
|
AU2005314236A1
(en)
*
|
2004-12-04 |
2006-06-15 |
The Regents Of The University Of California Los Alamos National Laboratory |
Protein-protein interaction detection system using fluorescent protein microdomains
|
US20060204999A1
(en)
*
|
2005-03-14 |
2006-09-14 |
Stephen Macevicz |
Detecting molecular complexes
|
NZ565938A
(en)
*
|
2005-08-19 |
2011-10-28 |
Commw Scient Ind Res Org |
Arachnocampa (Diptera) ATP-dependent luciferases
|
EP1948825A2
(en)
*
|
2005-10-27 |
2008-07-30 |
The Trustees Of Boston University |
Activated split-polypeptides and methods for their production and use
|
CN101365805A
(zh)
*
|
2005-10-27 |
2009-02-11 |
波士顿大学董事会 |
使用蛋白质互补在体内实时检测核酸
|
GB0523954D0
(en)
*
|
2005-11-24 |
2006-01-04 |
Ucb Celltech |
Bioassays
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US7601517B2
(en)
|
2006-01-10 |
2009-10-13 |
Stanford University |
Split protein self complementing fragments, systems, and methods of use thereof
|
US20100137163A1
(en)
|
2006-01-11 |
2010-06-03 |
Link Darren R |
Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
|
JP2009526519A
(ja)
*
|
2006-01-17 |
2009-07-23 |
セルーメン、インコーポレイテッド |
生物学的システム応答の予測方法
|
WO2007120522A2
(en)
|
2006-04-03 |
2007-10-25 |
Promega Corporation |
Permuted and nonpermuted luciferase biosensors
|
JP5290148B2
(ja)
|
2006-04-10 |
2013-09-18 |
ジェネンテック, インコーポレイテッド |
Disheveled(Dvl)PDZ修飾因子
|
US20070254338A1
(en)
*
|
2006-04-24 |
2007-11-01 |
Amgen Inc. |
Method for making recombinant protein using complementation dependent DHFR mutants
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
EP2481815B1
(en)
|
2006-05-11 |
2016-01-27 |
Raindance Technologies, Inc. |
Microfluidic devices
|
US9074242B2
(en)
|
2010-02-12 |
2015-07-07 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
CN101484806A
(zh)
|
2006-05-17 |
2009-07-15 |
协乐民公司 |
一种对组织进行自动分析的方法
|
US8178654B2
(en)
|
2006-05-23 |
2012-05-15 |
Stanford University |
Estrogen receptor intramolecular folding systems, estrogen receptor intramolecular folding sensors, methods of use thereof, methods of detecting ER ligands, and methods of detecting ER agonists and antagonists
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
WO2008133709A2
(en)
*
|
2006-10-27 |
2008-11-06 |
Trustees Of Boston University |
Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
|
EP2095119A2
(en)
*
|
2006-11-10 |
2009-09-02 |
Cellumen, Inc. |
Protein-protein interaction biosensors and methods of use thereof
|
JP2010517945A
(ja)
*
|
2007-02-05 |
2010-05-27 |
パンバイオ・リミテツド |
均一インビトロfecアッセイ及び成分
|
US8772046B2
(en)
|
2007-02-06 |
2014-07-08 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
WO2008130623A1
(en)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US20090075313A1
(en)
*
|
2007-05-04 |
2009-03-19 |
Stanford University |
Split protein fragments, split protein systems, methods of making split protein systems, and methods of using split protein systems
|
JP5137266B2
(ja)
|
2007-08-01 |
2013-02-06 |
独立行政法人科学技術振興機構 |
抗原濃度測定法
|
SI2188313T1
(en)
|
2007-08-21 |
2018-04-30 |
Amgen, Inc. |
HUMAN C-FMS ANTIGEN TRANSFER PROTEIN
|
WO2009032664A2
(en)
*
|
2007-08-31 |
2009-03-12 |
The Regents Of The University Of Michigan |
Methods and compositions for increasing biological molecule stability
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
EP2210104A4
(en)
*
|
2007-11-01 |
2011-02-23 |
Univ Arizona State |
CELL-FREE PROCEDURE FOR DETECTING PROTEIN-LIGAND INTERACTIONS
|
CA2705923A1
(en)
|
2007-11-16 |
2009-05-22 |
Nuvelo, Inc. |
Antibodies to lrp6
|
WO2009111073A2
(en)
*
|
2008-03-06 |
2009-09-11 |
Odyssey Thera, Inc. |
High-content and high throughput assays for identification of lipid-regulating pathways, and novel therapeutic agents for lipid disorders
|
WO2009142735A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Promega Corporation |
LUCIFERASE BIOSENSORS FOR cAMP
|
US12038438B2
(en)
|
2008-07-18 |
2024-07-16 |
Bio-Rad Laboratories, Inc. |
Enzyme quantification
|
EP2315629B1
(en)
|
2008-07-18 |
2021-12-15 |
Bio-Rad Laboratories, Inc. |
Droplet libraries
|
CA2734895C
(en)
*
|
2008-08-18 |
2014-06-17 |
Discoverx Corporation |
Receptor tyrosine kinase assays
|
NZ592591A
(en)
|
2008-11-03 |
2012-04-27 |
Molecular Partners Ag |
Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
|
US9388406B2
(en)
|
2008-11-17 |
2016-07-12 |
Cornell University |
System useful for reporting protein-protein interactions in the bacterial periplasm
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
EP3415235A1
(en)
|
2009-03-23 |
2018-12-19 |
Raindance Technologies Inc. |
Manipulation of microfluidic droplets
|
SG177395A1
(en)
|
2009-07-07 |
2012-02-28 |
Agency Science Tech & Res |
Methods of identifying a pair of binding partners
|
US8524457B2
(en)
|
2009-09-22 |
2013-09-03 |
William Patterson |
Method for the selection of specific affinity binders by homogeneous noncompetitive assay
|
WO2011042564A1
(en)
|
2009-10-09 |
2011-04-14 |
Universite De Strasbourg |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
JO3244B1
(ar)
|
2009-10-26 |
2018-03-08 |
Amgen Inc |
بروتينات ربط مستضادات il – 23 البشرية
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
US10837883B2
(en)
|
2009-12-23 |
2020-11-17 |
Bio-Rad Laboratories, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
CA2796055A1
(en)
|
2010-04-15 |
2011-10-20 |
Amgen Inc. |
Human fgf receptor and .beta.-klotho binding proteins
|
AR081361A1
(es)
|
2010-04-30 |
2012-08-29 |
Molecular Partners Ag |
Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
|
WO2011143339A1
(en)
|
2010-05-11 |
2011-11-17 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
US9290794B2
(en)
|
2010-05-11 |
2016-03-22 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
EP3447155A1
(en)
|
2010-09-30 |
2019-02-27 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
MX354481B
(es)
|
2010-10-27 |
2018-03-07 |
Amgen Inc |
Anticuerpos dkk1 y métodos de uso.
|
WO2012069655A2
(en)
|
2010-11-26 |
2012-05-31 |
Molecular Partners Ag |
Improved n-terminal capping modules for designed ankyrin repeat proteins
|
EP3412778A1
(en)
|
2011-02-11 |
2018-12-12 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
CN103649118A
(zh)
|
2011-03-01 |
2014-03-19 |
安进公司 |
双特异性结合剂
|
EP3553527A1
(en)
|
2011-03-17 |
2019-10-16 |
Cernostics, Inc. |
Systems and compositions for diagnosing barrett's esophagus and methods of using the same
|
KR20140039203A
(ko)
|
2011-04-29 |
2014-04-01 |
얀센 바이오테크 인코포레이티드 |
Il4/il13 결합 반복 단백질 및 용도
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
US9556470B2
(en)
|
2011-06-02 |
2017-01-31 |
Raindance Technologies, Inc. |
Enzyme quantification
|
US9574002B2
(en)
|
2011-06-06 |
2017-02-21 |
Amgen Inc. |
Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
WO2013033080A1
(en)
*
|
2011-08-29 |
2013-03-07 |
Wayne State University |
Device and method for optimizing photobiological processes
|
RU2014118491A
(ru)
|
2011-10-14 |
2015-11-20 |
Дженентек, Инк. |
Активаторы зимогенов
|
CN104220460A
(zh)
|
2011-12-08 |
2014-12-17 |
安姆根有限公司 |
激动人lcat抗原结合蛋白和它们在疗法中的用途
|
BR112014020119A2
(pt)
|
2012-02-13 |
2020-10-27 |
Gamida-Cell Ltd |
cultura de células-tronco mesenquimais
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
WO2013137920A1
(en)
|
2012-03-16 |
2013-09-19 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
SI3431492T1
(sl)
|
2012-04-27 |
2021-07-30 |
Novo Nordisk A/S |
Antigen-vezavni proteini liganda človeškega CD30
|
SG11201408196RA
(en)
|
2012-06-28 |
2015-03-30 |
Molecular Partners Ag |
Designed ankyrin repeat proteins binding to platelet-derived growth factor
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
EP2738180A1
(en)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Binding proteins comprising at least two binding domains against HER2.
|
EP2970451A1
(en)
|
2013-03-14 |
2016-01-20 |
Amgen Inc. |
Chrdl-1 antigen binding proteins and methods of treatment
|
DK2970412T3
(da)
|
2013-03-15 |
2022-08-29 |
Promega Corp |
Aktivering af bioluminescens via strukturel komplementering
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
WO2014144632A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Human pac1 antibodies
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
WO2015103367A1
(en)
|
2013-12-31 |
2015-07-09 |
Raindance Technologies, Inc. |
System and method for detection of rna species
|
SG11201705495XA
(en)
|
2014-01-14 |
2017-08-30 |
Asedasciences Ag |
Identification of functional cell states
|
AU2015224552A1
(en)
*
|
2014-03-03 |
2016-09-15 |
Novogy, Inc. |
Reducing horizontal gene transfer of functional proteins
|
JP6159486B2
(ja)
|
2014-06-12 |
2017-07-05 |
アクシオン バイオシステムズ, インコーポレイテッド |
光学的刺激を有するマルチウェル微小電極アレイ
|
JP6438118B2
(ja)
*
|
2014-08-27 |
2018-12-12 |
エルジー エレクトロニクス インコーポレイティド |
無線通信システムにおけるデータ送信方法及びこのための装置
|
WO2016040767A2
(en)
|
2014-09-12 |
2016-03-17 |
Amgen Inc. |
Chrdl-1 epitopes and antibodies
|
CN105406948B
(zh)
*
|
2014-09-12 |
2020-03-06 |
中兴通讯股份有限公司 |
一种实现并行多用户数据传输的方法及主节点
|
RU2680193C2
(ru)
*
|
2014-10-01 |
2019-02-18 |
ЭлДжи ЭЛЕКТРОНИКС ИНК. |
Способ передачи данных в системе беспроводной связи и устройство для его осуществления
|
US9942055B2
(en)
*
|
2015-02-12 |
2018-04-10 |
Intel IP Corporation |
Apparatus, system and method of multicast communication
|
JOP20200116A1
(ar)
|
2015-04-24 |
2017-06-16 |
Amgen Inc |
طرق لعلاج أو الوقاية من الصداع النصفي
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
WO2017112824A2
(en)
|
2015-12-23 |
2017-06-29 |
Amgen Inc. |
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
|
WO2017182437A1
(en)
|
2016-04-18 |
2017-10-26 |
Universität Innsbruck |
Quantification of an interaction between a ras protein and a raf protein
|
EP3493855A4
(en)
|
2016-08-02 |
2020-04-01 |
ISI Life Sciences, Inc. |
METHOD FOR DETECTION OF CANCER CELLS.
|
US10239891B2
(en)
*
|
2017-05-15 |
2019-03-26 |
Indicator Systems International, Inc. |
Compositions to detect remnant cancer cells
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
EP3519830B1
(en)
|
2016-09-29 |
2023-07-19 |
KinCon biolabs GmbH |
Full length kinase activity-conformation reporter
|
MX2019008029A
(es)
|
2017-01-06 |
2019-12-11 |
Abl Bio Inc |
Anticuerpo anti-alfa-sinucleina y su uso.
|
WO2018128454A1
(ko)
|
2017-01-06 |
2018-07-12 |
에이비엘바이오 주식회사 |
항 α-SYN 항체 및 그 용도
|
JOP20190177A1
(ar)
|
2017-01-17 |
2019-07-16 |
Amgen Inc |
طريقة لعلاج أو تحسين اضطرابات أيضية باستخدام مساعدات مستقبل glp-1 مقترنة بمناهضات لمستقبل ببتيد مثبط معوي (gipr)
|
US10753942B2
(en)
|
2017-05-15 |
2020-08-25 |
Indicator Systems International, Inc. |
Methods to detect remnant cancer cells
|
JOP20190259A1
(ar)
|
2017-05-31 |
2019-10-31 |
Amgen Inc |
بروتينات ربط مولد ضد مضادة لـ jagged1
|
CN110831969B
(zh)
|
2017-06-20 |
2024-06-21 |
安进公司 |
使用抑胃肽受体(gipr)结合蛋白与glp-1激动剂的组合治疗或改善代谢障碍的方法
|
JP7504025B2
(ja)
|
2017-08-04 |
2024-06-21 |
アムジエン・インコーポレーテツド |
Cys-mabのコンジュゲーション方法
|
WO2019030759A1
(en)
|
2017-08-08 |
2019-02-14 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
CHLORAMPHENICOL-RESISTANT TRUNCATED PROTEIN AND USES THEREOF
|
WO2019117684A1
(ko)
|
2017-12-14 |
2019-06-20 |
에이비엘바이오 주식회사 |
a-syn/IGF1R에 대한 이중 특이 항체 및 그 용도
|
WO2019225787A1
(ko)
|
2018-05-24 |
2019-11-28 |
에이비엘바이오 주식회사 |
항-b7-h3 항체 및 그 용도
|
GB2590302B
(en)
|
2018-07-06 |
2023-03-22 |
The Regents Of The Univ Of Colorado A Body Corporate Existing Under The Laws Of The State Of Colorad |
Genetically encoded system for constructing and detecting biologically active agents
|
CN111198272B
(zh)
*
|
2018-11-20 |
2023-09-08 |
香港理工大学深圳研究院 |
体外检测蛋白间相互作用的方法和检测试剂盒及其应用
|
EP3894549B1
(en)
|
2018-12-10 |
2024-07-31 |
Amgen Inc. |
Mutated piggybac transposase
|
CA3153963A1
(en)
*
|
2019-09-09 |
2021-03-18 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods of restoring lysosomal function of retinal pigment epithelial cells by activation of tfeb
|
US20220389099A1
(en)
|
2019-11-04 |
2022-12-08 |
Amgen Inc. |
Methods for treating leukemia
|
CA3165802A1
(en)
*
|
2020-01-25 |
2021-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions for small molecule control of precise base editing of target nucleic acids and methods of use thereof
|
IL297237A
(en)
|
2020-04-17 |
2022-12-01 |
Regeneron Pharma |
Detection tests for antibodies that neutralize the corona virus
|
AU2021345124A1
(en)
|
2020-09-16 |
2023-03-30 |
Amgen Inc. |
Methods for administering therapeutic doses of bispecific T-cell engaging molecules for the treatment of cancer
|
WO2022060878A1
(en)
|
2020-09-16 |
2022-03-24 |
Amgen Inc. |
Methods for treating prostate cancer
|
TW202233660A
(zh)
|
2020-10-30 |
2022-09-01 |
美商安進公司 |
過表現胰島素樣生長因子受體突變體以調節igf補充
|
CN112375775A
(zh)
*
|
2020-11-16 |
2021-02-19 |
中南民族大学 |
一种基于片段化萤光素酶-dna嵌合体互补的发光体系、构建方法及其应用
|
KR20230110298A
(ko)
*
|
2020-11-17 |
2023-07-21 |
너드 바이오 엘엘씨 |
고처리량 약물 스크리닝 방법
|
WO2022232376A1
(en)
|
2021-04-29 |
2022-11-03 |
Amgen Inc. |
Methods for reducing low molecular weight species of recombinantly-produced proteins
|
UY39807A
(es)
|
2021-06-10 |
2022-12-30 |
Amgen Inc |
VARIANTES GENOMODIFICADAS DE LA NRG-1 CON UNA SELECTIVIDAD MEJORADA FRENTE AL ErbB4 PERO NO FRENTE A
|
TW202328442A
(zh)
|
2021-09-10 |
2023-07-16 |
美商安進公司 |
平臺宿主對igf—培養基之適應
|
WO2023183231A1
(en)
|
2022-03-21 |
2023-09-28 |
Amgen Inc. |
Combination therapy methods with t-cell engaging molecules for treatment of prostate cancer
|
WO2024064744A2
(en)
*
|
2022-09-20 |
2024-03-28 |
Dna Twopointo, Inc. |
Engineered split dhfr-based methods and systems for selecting cells that have stably acquired a heterologous polynucleotide
|
WO2024077044A1
(en)
|
2022-10-05 |
2024-04-11 |
Amgen Inc. |
Combination therapies comprising t-cell redirecting therapies and agonistic anti-il-2r antibodies or fragments thereof
|
WO2024089297A1
(en)
|
2022-10-28 |
2024-05-02 |
Urban Joerg |
Novel fluorescent and bioluminescent proteins and reporter systems for ratiometric measurement of luminescence
|
WO2024163713A1
(en)
|
2023-02-02 |
2024-08-08 |
Amgen Inc. |
Mitigation of therapeutic protein fragmentation during cell culture harvest processes
|